die('
Site is under construction
Dear site users
Site is under construction.
The site will be ready in less than 24 hours.
We are sorry for the inconvenience.
www.yektaweb.com
');
Reports of Biochemistry and Molecular Biology
rbmb.net
Basic Sciences
http://rbmb.net
1
admin
2322-3480
2322-3480
10.61882/rbmb
en
jalali
1401
8
1
gregorian
2022
11
1
11
3
online
1
fulltext
en
Can Micro RNA-24 Affect the Cardiovascular Morbidity in Systemic Lupus Erythematosus by Targeting YKL-40?
بیوشیمی
Biochemistry
مقالات اصلی
Original Article
<div style="text-align: justify;"><strong>Background</strong>: Systemic lupus erythematosus (SLE) is an autoimmune disease with inflammatory nature. One of the leading causes of death in SLE patients is cardiovascular (CVS) morbidity. MiRNA-24 is highly expressed in vascular endothelial cells (VECs). This dysregulated expression pattern is associated with dysfunction or even damage of VECs and leads to the occurrence of cardiovascular diseases. YKL- 40 is an inflammatory glycoprotein involved in the pathogenesis of endothelial dysfunction and thereby atherosclerosis. In this work, we aimed at illustrating the possible role of miR-24 and its target YKL-40 in the pathogenesis of the CVS morbidity associated with SLE.<br>
<br>
<strong>Methods</strong>: This work was conducted on 40 SLE patients and 40 healthy controls. Quantitative realtime PCR (qPCR) was done to estimate the expression level of miRNA-24 in serum. In addition, we measured the serum level of YKL-40 using ELISA.<br>
<br>
<strong>Results</strong>: miR-24-fold change was found to be down-regulated, whereas serum YKL- 40 was upregulated among SLE patients with observed significant and negative correlation between the two parameters.<br>
<br>
<strong>Conclusions</strong>: Our study provided an insight about the role of miR-24 and its target serum YKL-40 protein in the development of SLE-related inflammation and atherosclerosis.</div>
miRNA-24, SDC-1, SLE, VCAM, YKL-40.
511
523
http://rbmb.net/browse.php?a_code=A-10-883-1&slc_lang=en&sid=1
Maha
Alhelf
100319475328460016760
100319475328460016760
No
Biotechnology School, Nile University, Giza, Egypt.
Laila
Rashed
100319475328460016761
100319475328460016761
No
Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University,Cairo, Egypt.
Sahar
Ahmed
100319475328460016762
100319475328460016762
No
Rheumatologyand Immunology Unit, Internal Medicine Department, Faculty ofMedicine, Cairo University, Cairo, Egypt.
Mohamed
Mohamed
100319475328460016763
100319475328460016763
No
Endocrinology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Marwa
Abdelgwad
Marwa.Soliman@kasralainy.edu.eg.
100319475328460016764
100319475328460016764
Yes
Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University,Cairo, Egypt.